| No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
| 1 |
chr6:107142600-107157400 |
Weak transcription |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
| 2 |
chr6:107149000-107152800 |
Weak transcription |
iPS-20b Cell Line |
embryonic stem cell
|
| 3 |
chr6:107149600-107151000 |
Flanking Active TSS |
Primary B cells from cord blood |
blood
|
| 4 |
chr6:107149600-107151000 |
Enhancers |
Fetal Thymus |
thymus
|
| 5 |
chr6:107149600-107151200 |
Enhancers |
Fetal Intestine Small |
intestine
|
| 6 |
chr6:107149800-107151000 |
Flanking Active TSS |
GM12878-XiMat |
blood
|
| 7 |
chr6:107149800-107151400 |
Enhancers |
Primary hematopoietic stem cells |
blood
|
| 8 |
chr6:107149800-107152000 |
Enhancers |
Stomach Mucosa |
stomach
|
| 9 |
chr6:107150000-107151000 |
Flanking Active TSS |
Primary B cells from peripheral blood |
blood
|
| 10 |
chr6:107150000-107151000 |
Enhancers |
Fetal Intestine Large |
intestine
|
| 11 |
chr6:107150000-107151000 |
Enhancers |
Rectal Mucosa Donor 31 |
rectum
|
| 12 |
chr6:107150000-107151000 |
Flanking Active TSS |
Dnd41 |
blood
|
| 13 |
chr6:107150000-107151200 |
Enhancers |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
| 14 |
chr6:107150000-107151200 |
Flanking Active TSS |
HepG2 |
liver
|
| 15 |
chr6:107150000-107152200 |
Enhancers |
Primary neutrophils fromperipheralblood |
blood
|
| 16 |
chr6:107150000-107152400 |
Enhancers |
Pancreas |
Pancrea
|
| 17 |
chr6:107150200-107151000 |
Enhancers |
Fetal Kidney |
kidney
|
| 18 |
chr6:107150400-107151000 |
Enhancers |
Esophagus |
oesophagus
|
| 19 |
chr6:107150600-107151000 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
| 20 |
chr6:107150600-107151000 |
Flanking Active TSS |
Duodenum Mucosa |
Duodenum
|
| 21 |
chr6:107150600-107151000 |
Bivalent/Poised TSS |
Osteobl |
bone
|
| 22 |
chr6:107150800-107151000 |
Flanking Active TSS |
Rectal Mucosa Donor 29 |
rectum
|
| 23 |
chr6:107150800-107151200 |
Flanking Active TSS |
Liver |
Liver
|
